Advancing Bispecific Discovery & Development

Time: 3:00 pm
day: Conference Day One


• Identifying the key challenges in optimizing bispecific antibody candidates using tumour models

• Exploring a method to enhance the therapeutic potential of bispecific antibodies through rational design and in vivo validation in tumour models

• Discussing strategies for effectively translating preclinical data into clinical applications, including safety assessment and dosing strategies